Drug & Therapeutics Committee

The Cluster and Hospital DTCs play an essential supportive role in the management of the HA Drug Formulary alongside their respective functions at the cluster / hospital level.

Terms of Reference

The Terms of Reference of Cluster and Hospital DTCs in respect of Drug Formulary management are:

1. To implement DMC policies / guidelines and monitor / follow up DMC initiatives;
2. To channel frontline feedback on management and operation of the HA Drug Formulary to DMC (via respective Cluster DTC);
3. To disseminate DMC, DAC and DFC’s information among cluster hospitals and collate feedback;
4. To approve programmes on compassionate use of unregistered drugs and drug samples as proposed by pharmaceutical companies; and
5. To manage cluster and hospital drug list and review the need for non-formulary drugs regularly.

Composition

Cluster and Hospital DTCs are chaired by their respective Cluster and Hospital Chief Executive or his / her delegate. Members include Chief of Service of related specialties, Cluster Clinical Stream Coordinators, General Manager (Nursing) and pharmacists with a defined tenure. Cluster and Hospital DTCs may enlist additional members to meet operational needs, as and when required.